1Wen R,Zhou G,Xie S,et al.Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2[J] Zhonghua Wai Ke Za Zhi,1998,36 (4):247-248.
2Lim JH,Park JK,Jo EK,et al.Purification and immunoreactivity of three components from the 30/32-Kllodalton antigen 85 complex in Mycobacterium tuberculosis[J].Infect Immun,1999,67 (11):6 187-6 190.
3Zlotta AR,Drowart A,Van Vooren JP,et al.Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus calmette-guerin therapy[J].J Urol,1998,159 (6):1 885-1 891.
4Kuromatsu I,Matsuo K,Takamura S,et al.Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria[J].Cancer Gene Ther,2001,8 (7):483-490.
5金冬雁 黎孟枫译.分子克隆实验指南[M].北京：科学出版社,1992.860.
6Bentley Hibbert SI,Quan X,Newman T,et al.Pathophysiology of antigen 85 in patients with active tuberculosis:antigen 85 circulates as complexes with fibronectin and immunoglobulin G[J].Infect Immun,1999,67 (2):581-588.
5Han R F,Pan J G.Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials[J].Urology,2006,67(6):1216-1223.
6Harth G,Lee B Y,Wang J,et al.Novel insights into the genetics,biochemistry,and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis[J].Infect Immun,1996,64(8):3038-3047.
7Lim J H,Park J K,Jo E K,et al.Purification and immunoreactivity of three components from the 30/32-kilodalton antigen 85 complex in Mycobacterium tuberculosis[J].Infect Immun,1999,67(11):6187-6190.
8Kariyone A,Tamura T,Kano H,et al.Immunogenicity of Peptide-25 of Ag85B in Th1 development:role of IFN-gamma[J].Int Immunol,2003,15(10):1183-1194.
9Zlotta A R,Drowart A,Van-Vooren J P,et al.Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy[J].J Urol,1998,159(6):1885-1891.
10Kuromatsu I,Matsuo K,Takamura S,et al.Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria[J].Cancer Gene Ther,2001,8(7):483-490.
